Search for Clinical Trial Results

Sponsored By

Adenosquamous Carcinoma of the Endometrium - 9 Studies Found

Status Study
Active, not recruiting Study Name: Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer
Condition:
  • Endometrial Adenocarcinoma
  • Endometrial Adenosquamous Carcinoma<
    Date: 2011-03-01
    Interventions:
    • Drug: Akt Inhibitor MK2206 Giv
Recruiting Study Name: Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
Condition:
  • Endometrial Adenocarcinoma
  • Endometrial Adenosquamous Carcinoma<
    Date: 2007-06-25
    Interventions:
    • Radiation: 3-Dimensional Conformal Radiation Therapy

Completed Study Name: Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
Condition:
  • Endometrial Adenocarcinoma
  • Endometrial Adenosquamous Carcinoma<
    Date: 2000-07-05
    Interventions:
    • Drug: Doxorubicin Hydrochloride

Recruiting Study Name: Cabozantinib-S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer
Condition:
  • Endometrial Adenosquamous Carcinoma
  • Endometrial Clear Cell Aden
    Date: 2013-09-03
    Interventions:
    • Drug: Cabozantinib S-malate Gi
Active, not recruiting Study Name: Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer
Condition:
  • Endometrial Adenosquamous Carcinoma
  • Endometrial Clear Cell Aden
    Date: 2007-12-15
    Interventions:
    • Drug: Cisplatin Given IV or IP
Active, not recruiting Study Name: Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
Condition:
  • Endometrial Adenocarcinoma
  • Endometrial Adenosquamous Carcinoma<
    Date: 2011-09-24
    Interventions:
    • Drug: Carboplatin Given IV
Completed Study Name: Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer
Condition:
  • Endometrial Adenocarcinoma
  • Endometrial Adenosquamous Carcinoma<
    Date: 2010-09-25
    Interventions: Biological: Trebananib Given IV Other Names:
Active, not recruiting Study Name: Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
Condition:
  • Endometrial Adenocarcinoma
  • Endometrial Adenosquamous Carcinoma<
    Date: 2009-09-12
    Interventions:
    • Biological: Bevacizumab Given

Completed Study Name: Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus
Condition:
  • Endometrial Adenocarcinoma
  • Endometrial Adenosquamous Carcinoma<
    Date: 2003-07-08
    Interventions:
    • Other: Laboratory Biomarker Analysis